ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL

N/A

Manufactured by Walgreen Company

38 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL

ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Walgreen Company. The most commonly reported adverse reactions for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL include NAUSEA, UNDERDOSE, VOMITING, ABDOMINAL DISCOMFORT, AMNESIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL.

Top Adverse Reactions

NAUSEA2 reports
UNDERDOSE2 reports
VOMITING2 reports
ABDOMINAL DISCOMFORT1 reports
AMNESIA1 reports
BLINDNESS TRANSIENT1 reports
BLISTER1 reports
BURNING SENSATION1 reports
CHILLS1 reports
COVID 191 reports
DEVICE DIFFICULT TO USE1 reports
DIARRHOEA1 reports
DISEASE PROGRESSION1 reports
DISEASE RECURRENCE1 reports
DIVERTICULITIS1 reports
DIZZINESS1 reports
DRUG EFFECT DELAYED1 reports
DRUG INEFFECTIVE1 reports
DYSPNOEA1 reports
EYE PAIN1 reports
FOREIGN BODY IN THROAT1 reports
HEADACHE1 reports
HEART RATE INCREASED1 reports
LOSS OF CONSCIOUSNESS1 reports
MIDDLE INSOMNIA1 reports
MIGRAINE1 reports
NASOPHARYNGITIS1 reports
NEUTROPENIA1 reports
OCULAR DISCOMFORT1 reports
PARALYSIS1 reports
PLATELET COUNT DECREASED1 reports
PRODUCT DOSE OMISSION ISSUE1 reports
PRURITUS1 reports
SOMNOLENCE1 reports
URTICARIA1 reports

Report Outcomes

Out of 14 classified reports for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL:

Serious 71.4%Non-Serious 28.6%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female10 (76.9%)
Male3 (23.1%)

Reports by Age

Age 592 reports
Age 51 reports
Age 241 reports
Age 281 reports
Age 301 reports
Age 321 reports
Age 421 reports
Age 731 reports
Age 891 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL?

This profile reflects 38 FDA FAERS reports that mention ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL?

Frequently reported terms in FAERS include NAUSEA, UNDERDOSE, VOMITING, ABDOMINAL DISCOMFORT, AMNESIA, BLINDNESS TRANSIENT. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL?

Labeling and FAERS entries often list Walgreen Company in connection with ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.